Clinical Trials in Phoenix

Showing 11301-11320 of 14,291 trials

Study of Electrical Impedance Myography (EIM) in ALS

NCT02011204

This trial is studying Electrical Impedance Myography (EIM) for measuring muscle health. The trial is studying people with Amyotrophic Lateral Sclerosis (ALS), other neuromuscular diseases, and healthy volunteers to see if the EIM device can measure disease in muscle tissue.

Amyotrophic Lateral SclerosisMotor Neuron DiseaseCharcot-Marie-Tooth Disease+1 more

Skulpt, Inc.106 participantsStarted Nov 2013

Phoenix, Arizona, United States • Miami, Florida, United States • Boston, Massachusetts, United States +3 more locations

WITHDRAWNPhase 2< 1 mile

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

NCT02174263

This phase II trial studies how well tocilizumab works in treating chronic graft-versus-host disease (GVHD) in patients that have not responded to treatment after at least two prior therapies. Tocilizumab blocks a protein that stimulates the body's immune system. By blocking this protein, the investigators may reduce the symptoms of chronic GVHD.

Graft Versus Host Disease

Fred Hutchinson Cancer CenterStarted Feb 2016

Phoenix, Arizona, United States • Rochester, Minnesota, United States • Nashville, Tennessee, United States +2 more locations

Study of Electrical Impedance Myography (EIM) in ALS

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

Find Trials by Condition in Phoenix

Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia

28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Strattice in Repair of Inguinal Hernias

Spectroscopy Versus Standard Care in Cervical Cancer Patients